Earnings Scheduled For February 11, 2014

CVS Caremark CVS is expected to report its Q4 earnings at $1.11 per share on revenue of $32.67 billion. The Mosaic Company MOS is projected to report its Q4 earnings at $0.44 per share. Dean Foods Company DF is estimated to report its Q4 earnings at $0.19 per share on revenue of $2.27 billion. Sprint S is projected to report a Q4 loss at $0.32 per share. Entergy ETR is expected to report its Q4 earnings at $0.81 per share on revenue of $2.49 billion. Omnicom Group OMC is projected to report its Q4 earnings at $1.16 per share on revenue of $4.03 billion. HCP HCP is estimated to report its Q4 earnings at $0.74 per share on revenue of $510.39 million. Huntsman HUN is projected to report its Q4 earnings at $0.37 per share on revenue of $2.70 billion. PG&E PCG is estimated to report its Q4 earnings at $0.41 per share on revenue of $3.90 billion. Packaging Corporation of America PKG is expected to post its Q4 earnings at $0.89 per share on revenue of $1.22 billion. Fossil Group FOSL is projected to post its Q4 earnings at $2.43 per share on revenue of $1.02 billion. IntercontinentalExchange Group ICE is expected to report its Q4 earnings at $1.95 per share on revenue of $620.19 million. Ingersoll-Rand Plc IR is estimated to report its Q4 earnings at $0.62 per share on revenue of $3.03 billion. DaVita HealthCare Partners DVA is projected to post its Q4 earnings at $0.98 per share on revenue of $3.02 billion. Henry Schein HSIC is expected to report its Q4 earnings at $1.40 per share on revenue of $2.53 billion. TripAdvisor TRIP is projected to post its Q4 earnings at $0.21 per share on revenue of $205.28 million. Charles River Laboratories International CRL is projected to post its Q4 earnings at $0.68 per share on revenue of $289.56 million. Marsh & McLennan Companies MMC is estimated to report its Q4 earnings at $0.56 per share on revenue of $3.13 billion. Arch Capital Group ACGL is projected to post its Q4 earnings at $0.96 per share on revenue of $646.52 million. Reynolds American RAI is expected to report its Q4 earnings at $0.81 per share on revenue of $2.07 billion. Dr. Reddy's Laboratories RDY is projected to report its Q3 earnings at $0.45 per share on revenue of $558.20 million. The Andersons ANDE is estimated to post its Q4 earnings at $1.61 per share on revenue of $1.74 billion. Regeneron Pharmaceuticals REGN is expected to report its Q4 earnings at $0.98 per share on revenue of $580.47 million. Genesee & Wyoming GWR is estimated to report its Q4 earnings at $1.16 per share on revenue of $398.12 million.